Ellagic acid, an NF-kappaB inhibitor, ameliorates renal function in experimental diabetic nephropathy.
Diabetic nephropathy (DN) is a serious complication confronted by diabetic patients. Available data indicate that the development of DN is linked to inflammation. In this context, nuclear factor-kappa B (NF-kappaB) has received much attention. Ellagic aci.....